Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Person › Details

Mary-Jane Elliott (Consilium Strategic Communications Ltd.)

Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications)

	Organisation	Consilium Strategic Communications Ltd.
	Today	ICR Consilium (Consilium Strategic Communications Ltd.)
	Group	ICR (Group)
	Former/major organisation	M:Communications (division of King Worldwide)
	Group	King Worldwide (Group)
	Product	public relations / investor relations / marcom (services)
	Product 2	LIFE SCIENCES

Record changed: 2024-12-18

Picture Berlin Partner Top News Robotics Network Berlin-Brandenburg 650x200px

More documents for Mary-Jane Elliott

[1] ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London....
[2] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
[3] MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug....
[4] MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug....
[5] Oxford Biomedica plc. (12/22/22). "Press Release: Oxford Biomedica to Present at 41st Annual J.P. Morgan Healthcare Conference". Oxford....
[6] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
[7] Silence Therapeutics plc. (10/15/21). "Press Release: Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence’s mRNAi GOLD™ Platform". London & Shanghai....
[8] Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London....
[9] Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London....
[10] Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]